Patents by Inventor Paul Rushton
Paul Rushton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11922515Abstract: Platform-agnostic digital assistant methods and apparatuses are provided. The apparatuses and methods include a processor configured by a memory to receive user data from a storage containing informational contents. The processor is configured to establish a communication channel with an entity and utilize the communication channel to receive first information related to a user. The processor is configured to extract at least one user datum from the first information and modify the informational contents of the storage based on at least one of the user datum and the first information. The processor is further configured to initiate an action related to the user based on at least one of the first information, the user datum, and the informational contents.Type: GrantFiled: April 28, 2023Date of Patent: March 5, 2024Assignee: Peppercorn AI Technology LimitedInventors: Nigel Lombard, Paul Cassidy, Atul Thakor, Robert Rushton, Ian Law, Christopher Hill, Jonathan Byford, Jonathan Wilshire, Andrew Snuggs
-
Publication number: 20230383303Abstract: The present technology provides trichome specific promoters of cannabinoid biosynthesis enzyme genes from Cannabis, nucleotide sequences of the trichome specific promoters, and uses of the promoters for modulating the production of cannabinoids and other compounds in organisms. The present technology also provides chimeric genes, vectors, and transgenic cells and organisms, including plant cells and plants, comprising the trichome specific promoters. Also provided are methods for expressing nucleic acid sequences in cells and organisms using the trichome specific promoters.Type: ApplicationFiled: April 11, 2023Publication date: November 30, 2023Applicant: 22nd Century Limited, LLCInventor: Paul Rushton
-
Publication number: 20230374531Abstract: The present technology provides trichome specific promoters of cannabinoid biosynthesis enzyme genes from Cannabis, nucleotide sequences of the trichome specific promoters, and uses of the promoters for modulating the production of cannabinoids and other compounds in organisms. The present technology also provides chimeric genes, vectors, and transgenic cells and organisms, including plant cells and plants, comprising the trichome specific promoters. Also provided are methods for expressing nucleic acid sequences in cells and organisms using the trichome specific promoters.Type: ApplicationFiled: April 10, 2023Publication date: November 23, 2023Applicant: 22nd Century Limited, LLCInventor: Paul Rushton
-
Patent number: 11649463Abstract: The present technology provides trichome specific promoters of cannabinoid biosynthesis enzyme genes from Cannabis, nucleotide sequences of the trichome specific promoters, and uses of the promoters for modulating the production of cannabinoids and other compounds in organisms. The present technology also provides chimeric genes, vectors, and transgenic cells and organisms, including plant cells and plants, comprising the trichome specific promoters. Also provided are methods for expressing nucleic acid sequences in cells and organisms using the trichome specific promoters.Type: GrantFiled: August 6, 2020Date of Patent: May 16, 2023Assignee: 22nd Century Limited, LLCInventor: Paul Rushton
-
Publication number: 20220325294Abstract: The present technology provides terpene synthase (TPS) promoters and TPS promoter consensus sequences from Cannabis, nucleotide sequences of the TPS promoters and consensus sequences, and uses of the promoters and consensus sequences for modulating the production of terpenes and other compounds in organisms The present technology also provides chimeric genes, vectors, and transgenic cells and organisms, including plant cells and plants, comprising the TPS promoters and consensus sequences. Also provided are methods for expressing nucleic acid sequences in cells and organisms using the TPS promoters and consensus sequences.Type: ApplicationFiled: June 30, 2020Publication date: October 13, 2022Applicant: 22nd Century Limited, LLCInventors: Paul Rushton, Sujon Sarowar
-
Publication number: 20210371870Abstract: The present technology provides dominant negative forms of transcription factors for modifying nicotine biosynthesis and nucleic acid molecules that encode such dominant negative transcription factors. Also provided are methods of using these nucleic acids to modulate nicotine production in plants and for producing plants and plant cells having reduced nicotine content.Type: ApplicationFiled: December 23, 2020Publication date: December 2, 2021Applicant: 22nd Century Limited, LLCInventor: Paul Rushton
-
Publication number: 20210371869Abstract: The present technology provides transcription factors for modifying plant metabolism and nucleic acid molecules that encode such transcription factors. Also provided are methods of using these nucleic acids to modulate alkaloid production in plants and for producing plants and cells having altered alkaloid content.Type: ApplicationFiled: December 30, 2020Publication date: December 2, 2021Applicant: 22nd Century Limited, LLCInventor: Paul Rushton
-
Publication number: 20210040492Abstract: The present technology provides trichome specific promoters of cannabinoid biosynthesis enzyme genes from Cannabis, nucleotide sequences of the trichome specific promoters, and uses of the promoters for modulating the production of cannabinoids and other compounds in organisms. The present technology also provides chimeric genes, vectors, and transgenic cells and organisms, including plant cells and plants, comprising the trichome specific promoters. Also provided are methods for expressing nucleic acid sequences in cells and organisms using the trichome specific promoters.Type: ApplicationFiled: August 6, 2020Publication date: February 11, 2021Applicant: 22nd Century Limited, LLCInventor: Paul Rushton
-
Patent number: 10787674Abstract: The present technology provides trichome specific promoters of cannabinoid biosynthesis enzyme genes from Cannabis, nucleotide sequences of the trichome specific promoters, and uses of the promoters for modulating the production of cannabinoids and other compounds in organisms. The present technology also provides chimeric genes, vectors, and transgenic cells and organisms, including plant cells and plants, comprising the trichome specific promoters. Also provided are methods for expressing nucleic acid sequences in cells and organisms using the trichome specific promoters.Type: GrantFiled: September 14, 2017Date of Patent: September 29, 2020Assignee: 22nd Century Limited, LLCInventor: Paul Rushton
-
Publication number: 20200140875Abstract: The present technology provides targeted genome engineering (also known as genome editing) techniques to modify nicotine biosynthesis. In particular, the present technology relates to the use of genome editing methods to generate mutations resulting in an out-of-frame start codon upstream of the open reading frames (ORFs) of genes of interest, such as nicotine biosynthesis genes, to genetically engineer protein translation levels and modulate nicotine production in plants for producing plants and plant cells having reduced nicotine content.Type: ApplicationFiled: May 30, 2018Publication date: May 7, 2020Applicant: 22nd Century Limited, LLCInventor: Paul Rushton
-
Publication number: 20190225975Abstract: The present technology provides trichome specific promoters of cannabinoid biosynthesis enzyme genes from Cannabis, nucleotide sequences of the trichome specific promoters, and uses of the promoters for modulating the production of cannabinoids and other compounds in organisms. The present technology also provides chimeric genes, vectors, and transgenic cells and organisms, including plant cells and plants, comprising the trichome specific promoters. Also provided are methods for expressing nucleic acid sequences in cells and organisms using the trichome specific promoters.Type: ApplicationFiled: September 14, 2017Publication date: July 25, 2019Applicant: 22nd Century Limited, LLCInventor: Paul Rushton
-
Publication number: 20190203215Abstract: The present technology provides transcription factors for modifying plant metabolism and nucleic acid molecules that encode such transcription factors. Also provided are methods of using these nucleic acids to modulate alkaloid production in plants and for producing plants and cells having altered alkaloid content.Type: ApplicationFiled: August 31, 2017Publication date: July 4, 2019Applicant: 22nd Century Limited, LLCInventor: Paul Rushton
-
Publication number: 20180340180Abstract: The present technology provides dominant negative forms of transcription factors for modifying nicotine biosynthesis and nucleic acid molecules that encode such dominant negative transcription factors. Also provided are methods of using these nucleic acids to modulate nicotine production in plants and for producing plants and plant cells having reduced nicotine content.Type: ApplicationFiled: May 18, 2018Publication date: November 29, 2018Applicant: 22nd Century Limited, LLCInventor: Paul Rushton
-
Patent number: 9631198Abstract: Described are synthetic promoters capable of mediating gene expression in plants upon pathogen infection. Furthermore, recombinant genes and vectors comprising said chimeric promoters as well as host cells transformed with such chimeric promoters, recombinant genes, or vectors are provided. Additionally, diagnostic compositions and kits comprising such chimeric promoters, recombinant genes, vectors or cells are described. Provided are further methods for the identification of compounds being capable of activating or inhibiting genes that are specifically expressed in plants upon pathogen infection employing the above described means. Furthermore, transgenic plant cells, plant tissue, and plants containing the above-described chimeric promoters, recombinant genes, and vectors as well as the use of the aforementioned chimeric promoters, recombinant genes, vectors and/or compounds identified by the method of the invention in plant cell and tissue culture, plant breeding, and/or agriculture are described.Type: GrantFiled: June 28, 2013Date of Patent: April 25, 2017Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.Inventors: Christoph Kirsch, Elke Logemann, Klaus Hahlbrock, Paul Rushton, Imre Somssich
-
Patent number: 9410159Abstract: Described are synthetic promoters capable of mediating gene expression in plants upon pathogen infection. Furthermore, recombinant genes and vectors comprising said chimeric promoters as well as host cells transformed with such chimeric promoters, recombinant genes, or vectors are provided. Additionally, diagnostic compositions and kits comprising such chimeric promoters, recombinant genes, vectors or cells are described. Provided are further methods for the identification of compounds being capable of activating or inhibiting genes that are specifically expressed in plants upon pathogen infection employing the above described means. Furthermore, transgenic plant cells, plant tissue, and plants containing the above-described chimeric promoters, recombinant genes, and vectors as well as the use of the aforementioned chimeric promoters, recombinant genes, vectors and/or compounds identified by the method of the invention in plant cell and tissue culture, plant breeding, and/or agriculture are described.Type: GrantFiled: June 28, 2013Date of Patent: August 9, 2016Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.Inventors: Christoph Kirsch, Elke Logemann, Klaus Hahlbrock, Paul Rushton, Imre Somssich
-
Patent number: 9297019Abstract: Described are synthetic promoters capable of mediating gene expression in plants upon pathogen infection. Furthermore, recombinant genes and vectors comprising said chimeric promoters as well as host cells transformed with such chimeric promoters, recombinant genes, or vectors are provided. Additionally, diagnostic compositions and kits comprising such chimeric promoters, recombinant genes, vectors or cells are described. Provided are further methods for the identification of compounds being capable of activating or inhibiting genes that are specifically expressed in plants upon pathogen infection employing the above described means. Furthermore, transgenic plant cells, plant tissue, and plants containing the above-described chimeric promoters, recombinant genes, and vectors as well as the use of the aforementioned chimeric promoters, recombinant genes, vectors and/or compounds identified by the method of the invention in plant cell and tissue culture, plant breeding, and/or agriculture are described.Type: GrantFiled: June 28, 2013Date of Patent: March 29, 2016Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.Inventors: Christoph Kirsch, Elke Logemann, Klaus Hahlbrock, Paul Rushton, Imre Somssich
-
Patent number: 9297018Abstract: Described are synthetic promoters capable of mediating gene expression in plants upon pathogen infection. Furthermore, recombinant genes and vectors comprising said chimeric promoters as well as host cells transformed with such chimeric promoters, recombinant genes, or vectors are provided. Additionally, diagnostic compositions and kits comprising such chimeric promoters, recombinant genes, vectors or cells are described. Provided are further methods for the identification of compounds being capable of activating or inhibiting genes that are specifically expressed in plants upon pathogen infection employing the above described means. Furthermore, transgenic plant cells, plant tissue, and plants containing the above-described chimeric promoters, recombinant genes, and vectors as well as the use of the aforementioned chimeric promoters, recombinant genes, vectors and/or compounds identified by the method of the invention in plant cell and tissue culture, plant breeding, and/or agriculture are described.Type: GrantFiled: June 28, 2013Date of Patent: March 29, 2016Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.Inventors: Christoph Kirsch, Elke Logemann, Klaus Hahlbrock, Paul Rushton, Imre Somssich
-
Publication number: 20140208455Abstract: Described are synthetic promoters capable of mediating gene expression in plants upon pathogen infection. Furthermore, recombinant genes and vectors comprising said chimeric promoters as well as host cells transformed with such chimeric promoters, recombinant genes, or vectors are provided. Additionally, diagnostic compositions and kits comprising such chimeric promoters, recombinant genes, vectors or cells are described. Provided are further methods for the identification of compounds being capable of activating or inhibiting genes that are specifically expressed in plants upon pathogen infection employing the above described means. Furthermore, transgenic plant cells, plant tissue, and plants containing the above-described chimeric promoters, recombinant genes, and vectors as well as the use of the aforementioned chimeric promoters, recombinant genes, vectors and/or compounds identified by the method of the invention in plant cell and tissue culture, plant breeding, and/or agriculture are described.Type: ApplicationFiled: June 28, 2013Publication date: July 24, 2014Applicant: MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.Inventors: Christoph Kirsch, Elke Logemann, Klaus Hahlbrock, Paul Rushton, Imre Somssich
-
Publication number: 20140068813Abstract: Described are synthetic promoters capable of mediating gene expression in plants upon pathogen infection. Furthermore, recombinant genes and vectors comprising said chimeric promoters as well as host cells transformed with such chimeric promoters, recombinant genes, or vectors are provided. Additionally, diagnostic compositions and kits comprising such chimeric promoters, recombinant genes, vectors or cells are described. Provided are further methods for the identification of compounds being capable of activating or inhibiting genes that are specifically expressed in plants upon pathogen infection employing the above described means. Furthermore, transgenic plant cells, plant tissue, and plants containing the above-described chimeric promoters, recombinant genes, and vectors as well as the use of the aforementioned chimeric promoters, recombinant genes, vectors and/or compounds identified by the method of the invention in plant cell and tissue culture, plant breeding, and/or agriculture are described.Type: ApplicationFiled: June 28, 2013Publication date: March 6, 2014Applicant: MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.Inventors: Christoph Kirsch, Elke Logemann, Klaus Hahlbrock, Paul Rushton, Imre Somssich
-
Publication number: 20140047581Abstract: Described are synthetic promoters capable of mediating gene expression in plants upon pathogen infection. Furthermore, recombinant genes and vectors comprising said chimeric promoters as well as host cells transformed with such chimeric promoters, recombinant genes, or vectors are provided. Additionally, diagnostic compositions and kits comprising such chimeric promoters, recombinant genes, vectors or cells are described. Provided are further methods for the identification of compounds being capable of activating or inhibiting genes that are specifically expressed in plants upon pathogen infection employing the above described means. Furthermore, transgenic plant cells, plant tissue, and plants containing the above-described chimeric promoters, recombinant genes, and vectors as well as the use of the aforementioned chimeric promoters, recombinant genes, vectors and/or compounds identified by the method of the invention in plant cell and tissue culture, plant breeding, and/or agriculture are described.Type: ApplicationFiled: June 28, 2013Publication date: February 13, 2014Applicant: MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.Inventors: Christoph Kirsch, Elke Logemann, Klaus Hahlbrock, Paul Rushton, Imre Somssich